Your session is about to expire
← Back to Search
Behavioral Intervention
Anticipating Decline and Providing Therapy (ADAPT) care for Mild Cognitive Impairment (ADAPT Trial)
N/A
Recruiting
Led By Jessica Palakshappa, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 60 and older at time of discharge from medical intensive care unit
Minimum 72 hour Intensive Care Unit stay in medical ICU at Atrium Health Wake Forest Baptist
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 12
Awards & highlights
ADAPT Trial Summary
This trial will compare the usual care given to older adults after they leave the ICU to a new screening and support program called ADAPT. The goal is to enroll 120 older adults in the study.
Who is the study for?
This trial is for older adults aged 60 or above who have been discharged from the ICU and may be at risk of post-intensive care syndrome, dementia, or other cognitive impairments. Specific eligibility details are not provided.Check my eligibility
What is being tested?
The study compares usual post-ICU care with a new intervention called ADAPT which includes screening and support to prevent cognitive decline. It's a randomized control trial aiming to enroll 120 participants.See study design
What are the potential side effects?
Since the interventions involve usual care practices and additional screening/support measures, side effects are not typical as with drug trials but could include emotional distress or fatigue.
ADAPT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 60 years old or older and was recently in the ICU.
Select...
I stayed in the ICU at Atrium Health Wake Forest Baptist for at least 72 hours.
ADAPT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ month 12
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 12
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of participants in Cognitive Screening Intervention Arm
Secondary outcome measures
Acceptability of Feasibility of Intervention measure (FIM) Scores
Acceptability of Intervention Appropriateness Measure (IAM) Scores
Acceptability of Intervention Measure (AIM) Scores
+7 moreOther outcome measures
Qualitative Perception
ADAPT Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Anticipating Decline and Providing Therapy (ADAPT) careExperimental Treatment1 Intervention
The program includes a routine validated cognitive screen for high-risk older adults at 6 weeks and 6 months post-ICU discharge
Group II: Usual CareActive Control1 Intervention
routine clinic visits
Find a Location
Who is running the clinical trial?
National Institute on Aging (NIA)NIH
1,675 Previous Clinical Trials
28,020,765 Total Patients Enrolled
Wake Forest University Health SciencesLead Sponsor
1,243 Previous Clinical Trials
1,004,606 Total Patients Enrolled
Jessica Palakshappa, MDPrincipal InvestigatorWake Forest University Health Sciences
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are participants currently being recruited for this ongoing trial?
"According to the information provided on clinicaltrials.gov, the study in question is not currently recruiting patients. The trial was first posted on January 1st, 2024 and was last updated on December 13th, 2023. However, it's worth noting that there are currently 1142 other trials actively seeking participants at this time."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger